Sentinel lymph node biopsy can be omitted in DCIS patients treated with breast conserving therapy

Breast cancer guidelines advise sentinel lymph node biopsy (SLNB) in patients with ductal carcinoma in situ (DCIS) on core biopsy at high risk of invasive cancer or in case of mastectomy. This study investigates the incidence of SLNB and SLN metastases and the relevance of indications in guidelines...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Breast Cancer Res Treat
Main Authors: van Roozendaal, L. M., Goorts, B., Klinkert, M., Keymeulen, K. B. M. I., De Vries, B., Strobbe, L. J. A., Wauters, C. A. P., van Riet, Y. E., Degreef, E., Rutgers, E. J. T., Wesseling, J., Smidt, M. L.
Formato: Artigo
Idioma:Inglês
Publicado em: Springer US 2016
Assuntos:
Clinical Trial
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4837213/
https://ncbi.nlm.nih.gov/pubmed/27083179
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10549-016-3783-2
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados